Literature DB >> 20739520

Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences.

Claro Yu1, Denali Boon, Shannon L McDonald, Timothy G Myers, Keiko Tomioka, Hanh Nguyen, Ronald E Engle, Sugantha Govindarajan, Suzanne U Emerson, Robert H Purcell.   

Abstract

The chimpanzee is the only animal model for investigating the pathogenesis of viral hepatitis types A through E in humans. Studies of the host response, including microarray analyses, have relied on the close relationship between these two primate species: chimpanzee samples are commonly tested with human-based reagents. In this study, the host responses to two dissimilar viruses, hepatitis E virus (HEV) and hepatitis C virus (HCV), were compared in multiple experimentally infected chimpanzees. Affymetrix U133+2.0 human microarray chips were used to assess the entire transcriptome in serial liver biopsies obtained over the course of the infections. Respecting the limitations of microarray probes designed for human target transcripts to effectively assay chimpanzee transcripts, we conducted probe-level analysis of the microarray data in conjunction with a custom mapping of the probe sequences to the most recent human and chimpanzee genome sequences. Time points for statistical comparison were chosen based on independently measured viremia levels. Regardless of the viral infection, the alignment of differentially expressed genes to the human genome sequence resulted in a larger number of genes being identified when compared with alignment to the chimpanzee genome sequence. This probably reflects the lesser refinement of gene annotation for chimpanzees. In general, the two viruses demonstrated very distinct temporal changes in host response genes, although both RNA viruses induced genes that were involved in many of the same biological systems, including interferon-induced genes. The host response to HCV infection was more robust in the magnitude and number of differentially expressed genes compared to HEV infection.

Entities:  

Mesh:

Year:  2010        PMID: 20739520      PMCID: PMC2953165          DOI: 10.1128/JVI.01205-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group.

Authors:  J Saldanha; N Lelie; A Heath
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

2.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

Authors:  H Okamoto; S Okada; Y Sugiyama; K Kurai; H Iizuka; A Machida; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

3.  Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.

Authors:  Jianguo Liu; Xiuqin Guan; Xiaojing Ma
Journal:  J Biol Chem       Date:  2005-04-27       Impact factor: 5.157

4.  Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.

Authors:  S L Anderson; J M Carton; J Lou; L Xing; B Y Rubin
Journal:  Virology       Date:  1999-03-30       Impact factor: 3.616

5.  In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.

Authors:  Akito Sakai; Shingo Takikawa; Robert Thimme; Jean-Christophe Meunier; Hans Christian Spangenberg; Sugantha Govindarajan; Patrizia Farci; Suzanne U Emerson; Francis V Chisari; Robert H Purcell; Jens Bukh
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

6.  Non-A, non-B hepatitis in chimpanzees and marmosets.

Authors:  S M Feinstone; H J Alter; H P Dienes; Y Shimizu; H Popper; D Blackmore; D Sly; W T London; R H Purcell
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

Review 7.  Molecular biology and pathogenesis of hepatitis E virus.

Authors:  Vivek Chandra; Shikha Taneja; Manjula Kalia; Shahid Jameel
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

8.  Immunoregulatory properties of ISG15, an interferon-induced cytokine.

Authors:  J D'Cunha; E Knight; A L Haas; R L Truitt; E C Borden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Hideyuki Takahashi; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Yasuyuki Yazaki; Tomofumi Takagi; Masahiro Azuma; Eiji Kusano; Norio Isoda; Kentaro Sugano; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

10.  The natural history of hepatitis C virus (HCV) infection.

Authors:  Stephen L Chen; Timothy R Morgan
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

View more
  45 in total

Review 1.  Small Animal Models of Hepatitis E Virus Infection.

Authors:  Tian-Cheng Li; Takaji Wakita
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

Review 2.  Clinical features and determinants of chronicity in hepatitis E virus infection.

Authors:  Shivakumar Narayanan; Ameer Abutaleb; Kenneth E Sherman; Shyam Kottilil
Journal:  J Viral Hepat       Date:  2019-02-05       Impact factor: 3.728

Review 3.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 4.  Innate Immunity to Enteric Hepatitis Viruses.

Authors:  Zongdi Feng; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

5.  Changes in gene expression in liver tissue from patients with fulminant hepatitis E.

Authors:  Anshu Naik; Amit Goel; Vinita Agrawal; Aditya N Sarangi; Nanda Chhavi; Vineeta Singh; Shahid Jameel; Rakesh Aggarwal
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

6.  Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.

Authors:  Daniel Todt; Catherine François; Patrick Behrendt; Michael Engelmann; Leonard Knegendorf; Gabrielle Vieyres; Heiner Wedemeyer; Rune Hartmann; Thomas Pietschmann; Gilles Duverlie; Eike Steinmann
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 7.  Nonhuman Primate Models of Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Robert E Lanford; Christopher M Walker; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

8.  Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors.

Authors:  Ronald E Engle; Jens Bukh; Harvey J Alter; Suzanne U Emerson; Joni L Trenbeath; Hanh T Nguyen; Alicia Brockington; Tanaji Mitra; Robert H Purcell
Journal:  Transfusion       Date:  2014-05-05       Impact factor: 3.157

9.  ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.

Authors:  Harini Sooryanarain; Adam J Rogers; Dianjun Cao; Mary Etna R Haac; Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

10.  An Epidemiologic Investigation of a Case of Acute Hepatitis E.

Authors:  Souvik Sarkar; Elenita M Rivera; Ronald E Engle; Hanh T Nguyen; Cathy A Schechterly; Harvey J Alter; T Jake Liang; Robert H Purcell; Jay H Hoofnagle; Marc G Ghany
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.